Le Lézard
Classified in: Covid-19 virus
Subject: ATY

KIND Investors Have Opportunity to Lead Nextdoor Holdings, Inc. Securities Fraud Lawsuit


LOS ANGELES, April 11, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ("Nextdoor" or the "Company") (NYSE: KIND).

Class Period: July 6, 2021 ? November 8, 2022
Lead Plaintiff Deadline: April 29, 2024

If you wish to serve as lead plaintiff of the Nextdoor lawsuit, you can submit your contact information at www.glancylaw.com/cases/Nextdoor-Holdings-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors: (1) that Nextdoor's financial results prior to the Merger had been temporarily inflated by the ephemeral effects of the COVID-19 pandemic, which had pulled forward demand for Nextdoor's platform and cannibalized future advertising revenue growth; (2) that, rather than being sustained, such growth trends had already begun reversing at the start of the Class Period; (3) that Nextdoor's total addressable market was materially smaller than the 312 million households represented to investors; (4) that, by the start of the Class Period, Nextdoor's most important market ? the U.S. market ? was already substantially saturated, impairing the Company's ability to monetize users and increase its ARPU or U.S. WAUs; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts 
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
[email protected]
www.glancylaw.com

SOURCE Glancy Prongay & Murray LLP


These press releases may also interest you

at 12:15
The "Global Car Subscription Market: Analysis By Vehicle Type, By Subscription Period, By Service Provider, By End User, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to...

at 11:30
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") and reminds investors of the June 11, 2024 deadline to seek the role of lead plaintiff...

at 10:15
The growing need for identity-centric security solutions brought on by an increase in cyberattacks and regulatory compliance requirements will define the Identity Threat Detection and Response (ITDR) Market in the future. The growth of ITDR solutions...

at 09:35
Red Pine Exploration Inc.  ("Red Pine" or the "Company"), further to its press releases of May 1, 2024, and May 6, 2024 (the "Prior Press Releases"), provides a further update on the Company's progress on its investigations into the reporting...

at 09:05
Hyperfine, Inc. , the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system?the Swoop® system?today announced it has entered into agreements with...

at 09:00
Applied DNA Sciences, Inc. (Applied DNA), a leader in PCR-based DNA technologies, today announced that on May 9, 2024, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq...



News published on and distributed by: